Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02655991 · ClinicalTrials.gov registry record · NA
Homecoming Line: Telephone Support for Veterans
A NA study of Stress Disorders, Post-Traumatic, sponsored by VA Palo Alto Health Care System.
- Completed
- Registry status
- NA
- Development phase
- 358
- Enrollment target
- 3
- Study locations
NCT02655991: Completed NA study of Stress Disorders, Post-Traumatic, sponsored by VA Palo Alto Health Care System.
NCT02655991 is a NA study of Stress Disorders, Post-Traumatic that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 358 participants, above the 151-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (137% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02655991, a NA study of Stress Disorders, Post-Traumatic, has completed, sponsored by VA Palo Alto Health Care System.
- COMPLETED
- Registry status
- NA
- Development phase
- 358 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will determine whether telephone support improves clinical outcomes of veterans who begin outpatient treatment for posttraumatic stress disorder. Participants will be randomly assigned to receive either usual care or usual care supplemented by biweekly monitoring and support by telephone during the first 3 months of treatment. Patients in both conditions will be compared on PTSD symptoms, engagement in treatment, violence and drinking at 4 months and 12 months after entering treatment.
Primary Outcome
Slope of improvement on the PTSD Checklist, a self-report measure of PTSD symptoms.
Conditions Studied
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Telephone Case Monitoring
Study Locations (3)
California
- VA Palo Alto Health Care System (Meno Park Division) - Menlo Park
North Carolina
- Durham VA Medical Center - Durham
Washington
- VA Puget Sound Health Care System (American Lake) - Lakewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2008-03 |
| Est. Completion | 2014-08 |
| Phase | NA |
What the finished NCT02655991 record still lists
NCT02655991 is an interventional study that assigns participants to a tested intervention. The registered 358 participants enrollment target is mid-sized for trials with a published cap, above the 151-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (137% higher).
The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT02655991 reports a single indexed study location in California, North Carolina, Washington.
Frequently Asked Questions
What is clinical trial NCT02655991 about?
NCT02655991 is a clinical study titled "Homecoming Line: Telephone Support for Veterans". This study will determine whether telephone support improves clinical outcomes of veterans who begin outpatient treatment for posttraumatic stress disorder. Participants will be randomly assigned to receive either usual care or usual care supplemented by biweekly monitoring and support by telephone ...
What is the current status of trial NCT02655991?
This trial is currently completed. It is a NA study. The enrollment target is 358 participants. The study started on 2008-03. Estimated completion is 2014-08.
What conditions does trial NCT02655991 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.
What interventions are being tested in trial NCT02655991?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Telephone Case Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT02655991?
This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02655991 being conducted?
This trial has 3 study locations across California, North Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02655991's enrollment target sits among peer trials
358 6th of 66 higher than 61 of 66 other Stress Disorders, Post-Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Healthy Recovery After Trauma Study
RECRUITING · NA
-
Intervention to Enhance Coping and Help-seeking Among Youth in Foster Care
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04373317 · 358 participants · Phase 4
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
- NCT05684965 · 358 participants · Phase 1
XTX301 in Patients With Advanced Solid Tumors
- NCT05824975 · 358 participants · Phase 1
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- NCT06480227 · 358 participants · NA
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia